Ulka Vaishampayan
@drulkav
Followers
99
Following
83
Media
8
Statuses
172
Joined April 2023
Congrats @neerajaiims and team. Exciting results in this publication.
Just came online in @TheLancet 👉Our two papers on improved OS with Enzalutamide + Talazoparib in mCRPC #ProstateCancer in all-comer & HRRm patients (Median OS and HRs👇). Weblinks to the papers👉 and @PCFnews @urotoday @OncoAlert
0
0
2
Excellent commentary with key points.
⚠️ The missing subplot in #KEYNOTE689 🧠💉.Yes, periop #pembrolizumab improved EFS in resectable LA-HNSCC. But what about crossover?.🧩 Not allowed. 📉 Post-progression therapy not reported. In a post–#KEYNOTE048 world, that’s a problem. 💣 Why it matters:.No ICI for progressing.
0
0
0
RT @KidneyCancer: This is a FREE event, open to anyone who would like to join us!
us02web.zoom.us
Welcome! You are invited to join a meeting: Women in RCC Summer 2025 Webinar. After registering, you will receive a confirmation email about joining the meeting.
0
5
0
Do not miss the famous and talented researcher @KimrynRathmell prior NCI director speaking about kidney cancer!.
🎉 We're so excited to have @KimrynRathmell @OSUCCC_James join us in conversation during the KCA's Women in RCC summer webinar next month! . 👉Register today:
0
2
6
VEGF and HIF combo synergy noted.
@brian_rini @BReinfeld @tompowles1 @DrChoueiri @montypal @PGrivasMDPhD @kidneycan @KidneyCancer @KidneyCancerDoc @HHammersMD Seems to me that toxicity for cas + Cabo seemed more favorable but hard to interpreted in single atm trial.
0
0
0
Congratulations @DrChoueiri .U have helped so many! Continue the impressive work!.Best wishes.
Congratulations @DrChoueiri , a mentor who has become family on receiving the Waun Ki Hong Outstanding Achievement Award! . Your work has transformed so many lives. Wishing I could be there to celebrate this so well deserved honor!
0
0
2
A paper highlighting the contemporary role of cytoreductive nephrectomy in met RCC. Consider PROBE trial.
0
0
0
Congrats @PGrivasMDPhD.
Congratulations to my dear friend @PGrivasMDPhD and to the @JCO_ASCO associate editor Thomas E. Stinchcombe!! @ASCO.
1
0
1
Very exciting’.
⭐️Tour de force CAR-T cell for renal cell cancer presentation by Dr. Tanya Dorff @cityofhope . These studies are currently open for clinical trial enrollment. Preliminary studies look very promising. @TDorffOnc . #MatosGU25 @PGrivasMDPhD @montypal . @ZakhariaYousef @HHammersMD
0
0
3
RT @CParkMD: ⭐️Tour de force CAR-T cell for renal cell cancer presentation by Dr. Tanya Dorff @cityofhope . These studies are currently ope….
0
14
0
RT @TylerSbrt: Please save the @DeptofDefense Prostate Cancer Research Program! We need continued funding to keep fighting #ProstateCancer….
0
34
0
Congrats for planning this!.
Excited to co-chair this first GU summit with @bilenma in Atlanta with great lineup of speakers @PBarataMD @CParkMD @RohanGarjeMD @maughanonc @binayshah @arnabguonc @virajmaster @DocMattCampbell @BasselNazha and many more can’t find on X, 15 travel grants offered to trainees.
0
0
1
Glad u pointed out this! @RCCadvocate.
70% of health-related internet searches are zero-click - which means pts are relying on snippets and AI overviews for information. When you see something like this that is outdated, misleading, or both - click on the feedback button. It's a small way you can help improve
0
1
4
Looking forward to a robust discussion on advanced RCC and audience participation. Warm invite to all Asco GU attendees.
There’s only one week left until our satellite symposium on key advances in renal cell carcinoma! Secure your spot now!. Join us in person: OR virtually: #MedicalOncology #GU25 @EJonasch @BradMcG04 @DrVaishampayan
0
2
2
Congrats.
.@walterstadler5 appointed chief clinical officer at City of Hope Cancer Center Chicago (@cityofhope).
0
0
0
Thanks to all my coauthors and the patients for their support in demonstrating preliminary success of a novel cytokine nemvaleukin. @muralcom @Alkermes.
New #JITC article: Nemvaleukin alfa, a modified interleukin-2 cytokine, as monotherapy and with pembrolizumab in patients with advanced solid tumors (ARTISTRY-1) @drulkav
0
0
0
Glad to see this confirmed. We already were seeing this clinically! Congrats @PBarataMD.
Hot of the press: our recent collaboration showing blood-based TMB not good predictive to IO in “cold tumors” breast and prostate cancers .@Nature @AlanBryce9 @TiansterZhang @bilenma @AarmstrongDuke @GuardantHealth .
0
0
0
RT @OncNewsCentral: Gilead withdraws #Trodelvy for advanced #BladderCancer after TROPiCS-04 trial fails to show survival benefit. Dr Ulka V….
oncologynewscentral.com
After the withdrawal of sacituzumab govitecan in metastatic bladder cancer, Ulka Vaishampayan, MBBS, discusses next steps, ongoing trials, and treatment options.
0
1
0
Inspiring discussion at #WIRCC at #IKCSNA24 panelists from every walk of research and clinical care and leadership.
Incredible #WiRCC session. Session opener from @ASCO CMO @jrgralow and amazing insights from panelists #DrNaomiHaas @drulkav #Dr. Henske @TiansterZhang @NaomiHaas5 #DrMoon #DrRangwala
0
1
3